Loading…
Moyamoya disease: A human model for chronic hypoperfusion and intervention in Alzheimer's disease
Introduction Chronic cerebral hypoperfusion has been considered the etiology for sporadic Alzheimer's disease (AD). However, no valid clinical evidence exists due to the similar risk factors between cerebrovascular disease and AD. Methods We used moyamoya disease (MMD) as a model of chronic hyp...
Saved in:
Published in: | Alzheimer's & dementia : translational research & clinical interventions 2022, Vol.8 (1), p.e12285-n/a |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Introduction
Chronic cerebral hypoperfusion has been considered the etiology for sporadic Alzheimer's disease (AD). However, no valid clinical evidence exists due to the similar risk factors between cerebrovascular disease and AD.
Methods
We used moyamoya disease (MMD) as a model of chronic hypoperfusion and cognitive impairment, without other etiology interference.
Results
Based on the previous reports and preliminary findings, we hypothesized that chronic cerebral hypoperfusion could be an independent upstream crucial variable, resulting in AD, and induce pathological hallmarks such as amyloid beta peptide and hyperphosphorylated tau accumulation.
Discussion
Timely intervention with revascularisation would help reverse the brain damage with AD hallmarks and lead to cognitive improvement. |
---|---|
ISSN: | 2352-8737 2352-8737 |
DOI: | 10.1002/trc2.12285 |